Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatrics

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2004-1238PMID 15741368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.

  2004cited by this paper
• Controlled trial of dexamethasone in neonatal chronic lung disease: an 8‐year follow‐up of cardiopulmonary function and growth

  2003cited by this paper
• Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.

  2003cited by this paper
• Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.

  2003cited by this paper
• Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

  2003cited by this paper
• Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.

  2002cited by this paper
• Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

  2002cited by this paper
• Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

  2002cited by this paper
• A three year follow up of preterm infants after moderately early treatment with dexamethasone

  2002cited by this paper
• 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント)

  2001cited by this paper
• Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

  2001cited by this paper
• Hypocarbia during the First 24 Postnatal Hours and White Matter Echolucencies in Newborns ≤28 Weeks Gestation

  2001cited by this paper
• The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs

  2001cited by this paper
• Early Dexamethasone—Attempting To Prevent Chronic Lung Disease

  2000cited by this paper
• More trials on early treatment with corticosteroids are needed

  2000cited by this paper
• Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

  2000cited by this paper
• Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants

  1999cited by this paper
• Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.

  1999cited by this paper
• Population-based study of chronic lung disease in very low birth weight infants in North Carolina in 1994 with comparisons with 1984. The North Carolina Neonatologists Association.

  1999cited by this paper
• Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age

  1999cited by this paper
• Early prediction of neonatal chronic lung disease: A comparison of three scoring methods

  1999cited by this paper
• Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants

  1999cited by this paper
• Effect on Growth of Two Different Dexamethasone Courses for Preterm Infants at Risk of Chronic Lung Disease

  1999cited by this paper
• Early dexamethasone therapy in preterm infants: a follow-up study.

  1998cited by this paper
• Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.

  1998cited by this paper
• Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity

  1998cited by this paper
• Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.

  1997cited by this paper
• Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants

  1997cited by this paper
• Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome.

  1996cited by this paper
• Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.

  1995cited by this paper
• Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant.

  1995cited by this paper
• Two Doses of Early Intravenous Dexamethasone for the Prevention of Bronchopulmonary Dysplasia in Babies with Respiratory Distress Syndrome

  1994cited by this paper
• Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.

  1993cited by this paper
• Randomized controlled trial of dexamethasone treatment in very‐low‐birth‐weight infants with ventilator‐dependent chronic lung disease

  1992cited by this paper
• Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group.

  1991cited by this paper
• Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation.

  1991cited by this paper
• Prediction of neurodevelopmental outcome in infants with and without bronchopulmonary dysplasia.

  1991cited by this paper
• INCREASED RISK OF CEREBRAL PALSY AMONG VERY LOW‐BIRTHWEIGHT INFANTS WITH CHRONIC LUNG DISEASE

  1990cited by this paper
• Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.

  1989cited by this paper
• A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

  1989cited by this paper
• Using Cerebral Palsy Data in the Evaluation of Neonatal Intensive Care: a Warning

  1982cited by this paper
• The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

  1977cited by this paper
• Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity.

  1975cited by this paper
• Sequelae of early steroid administration to the newborn infant.

  1974cited by this paper
• A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome.

  1972cited by this paper

• Postnatal corticosteroids and bronchopulmonary dysplasia: balancing pulmonary and neurologic effects to enable individualized decision-making.

  2026cites this paper
• Recurrent Pregnancy Loss

  2025cites this paper
• Neurodevelopmental Outcome at 20 Months Corrected Age in Extremely Preterm Infants After Exposure to Dexamethasone and Hydrocortisone in the NICU.

  2025cites this paper
• Neurological Development in Very Low Birth Weight Infants with Congenital Heart Disease at 3 Years of Age: A Japanese Multicenter Study.

  2025cites this paper
• Intratracheal instillation of corticosteroids combined with surfactant for preventing chronic lung disease in preterm infants

  2025cites this paper
• Association of early respiratory support with mortality and bronchopulmonary dysplasia in very-low-birth-weight preterm infants.

  2025cites this paper
• Impact of delayed cord clamping on mesenchymal, hemopoietic progenitor, and immune cells in very preterm neonates

  2025cites this paper
• Respiratory severity score-guided postnatal systemic corticosteroid therapy for bronchopulmonary dysplasia in extremely preterm infants

  2025influential citation
• Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia

  2025cites this paper
• The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi‐Prong Approach for a Heterogeneous Disease

  2025cites this paper
• Perinatal Treatment with Corticosteroids and Its Relation with Neurodevelopment in Premature Newborns: A Systematic Review of the Literature

  2025cites this paper
• Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.

  2024cites this paper
• Prevalence, Prevention and Management of Bronchopulmonary Dysplasia

  2024cites this paper
• Weaning from mechanical ventilation and assessment of extubation readiness.

  2024cites this paper
• Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia: Balancing Risk and Reward.

  2024cites this paper
• Beyond Bronchopulmonary Dysplasia: A Comprehensive Review of Chronic Lung Diseases in Neonates

  2024cites this paper
• Personalized lung care: Bronchopulmonary dysplasia risk prediction tool tailored for neonates born in resource‐limited settings

  2024cites this paper
• Salivary cortisol is not associated with dexamethasone response in preterm infants with evolving bronchopulmonary dysplasia

  2024cites this paper
• Analysis of the Association between In Vitro Fertilization/Assisted Conception and the Development of Retinopathy of Prematurity in Very-Low-Birth Weight Newborns

  2024cites this paper
• Systemic Postnatal Corticosteroids, Bronchopulmonary Dysplasia, and Survival Free of Cerebral Palsy.

  2024cites this paper
• EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?

  2023cites this paper
• Laparotomy or peritoneal drainage in preterm infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis?

  2023cites this paper
• How to Interact With Interactions: What Clinicians Should Know About Statistical Interactions.

  2023cites this paper
• Extrauterine growth restriction and low energy intake during the early neonatal period of very low birth weight infants are associated with decreased lung function in childhood

  2023cites this paper
• Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia

  2023cites this paper
• The possible role of artificial intelligence in deciding postnatal steroid management in extremely premature ventilated infants

  2023cites this paper
• Racial Disparities Among Predicted Bronchopulmonary Dysplasia Risk Outcomes in Premature Infants Born <30 Weeks Gestation

  2023cites this paper
• Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.

  2023cites this paper
• Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants

  2023cites this paper
• Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial

  2023cites this paper
• Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants

  2023cites this paper
• Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia

  2023cites this paper
• Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years’ corrected age: follow-up of a randomised clinical trial

  2023cites this paper
• A Dose-Limited Dexamethasone and Bubble Continuous Positive Airway Pressure in Ventilation-Dependent Extremely Premature Infants

  2022cites this paper
• Blood products transfusion and retinopathy of prematurity: A cohort study

  2022cites this paper
• Postnatal Corticosteroids to Prevent or Treat Chronic Lung Disease Following Preterm Birth.

  2022cites this paper
• Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.

  2022cites this paper
• Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort

  2022cites this paper
• Epidemiology and risk factors for bronchopulmonary dysplasia in preterm infants born at or less than 32 weeks of gestation.

  2022cites this paper
• Using dexamethasone wisely in invasively ventilated preterm infants

  2022cites this paper
• Let’s Talk about Dex: When do the Benefits of Dexamethasone for Prevention of Bronchopulmonary Dysplasia Outweigh the Risks?

  2022cites this paper
• Moving Bronchopulmonary Dysplasia Research from the Bedside to the Bench.

  2022cites this paper
• Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies

  2021cites this paper
• Steroid use for established bronchopulmonary dysplasia: study protocol for a systematic review and meta-analysis

  2021cites this paper
• Diagnosis and management of bronchopulmonary dysplasia

  2021cites this paper
• Preventing Brain Injury in the Preterm Infant—Current Controversies and Potential Therapies

  2021cites this paper
• Effectiveness and safety of repeat dexamethasone for bronchopulmonary dysplasia

  2021cites this paper
• The association between restricted intra-uterine growth and inadequate postnatal nutrition in very-low-birth-weight infants and their neurodevelopmental outcomes: a 50-month follow-up study

  2021cites this paper
• Efficacy of late postnatal dexamethasone on weaning from invasive mechanical ventilation in extreme premature infants

  2021cites this paper
• New Pharmacologic Approaches to Bronchopulmonary Dysplasia

  2021cites this paper
• Ventilation settings in preterm neonates with ventilator-dependant, evolving bronchopulmonary dysplasia.

  2021cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020cites this paper
• Early detection of cerebral palsy in high‐risk infants: Translation of evidence into practice in an Australian hospital

  2020cites this paper
• The Challenge of Risk Stratification of Infants Born Preterm in the Setting of Competing and Disparate Healthcare Outcomes.

  2020cites this paper
• Using quality improvement to implement consensus guidelines for postnatal steroid treatment of preterm infants with developing bronchopulmonary dysplasia

  2020cites this paper
• Intratracheal Transplantation of Amnion-Derived Mesenchymal Stem Cells Ameliorates Hyperoxia-Induced Neonatal Hyperoxic Lung Injury via Aminoacyl-Peptide Hydrolase

  2020cites this paper
• Ex Vivo MRI Analytical Methods and Brain Pathology in Preterm Lambs Treated with Postnatal Dexamethasone

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020cites this paper
• Glucocorticoid Treatment for Bronchopulmonary Dysplasia

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020cites this paper
• Pharmacological Therapies for the Prevention of Bronchopulmonary Dysplasia

  2020cites this paper
• Pediatric Pulmonology

  2020influential citation
• The Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years’ Corrected Age: Follow-Up of a Double-Blind, Placebo-Controlled, Multicentre, Randomised Trial

  2020cites this paper
• The challenge of risk stratification of preterm infants in the setting of competing and disparate healthcare outcomes

  2020cites this paper
• Timing of Postnatal Steroids for Bronchopulmonary Dysplasia: Association with Pulmonary and Neurodevelopmental Outcomes

  2020cites this paper
• Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.

  2020cites this paper
• Safety of Allogenic Human Cord Blood Derived Mononuclear Cells for Extreme Preterms Infants at High Risk of Death: A Descriptive Study

  2020cites this paper
• Functional outcome at school age of preterm-born children treated with low-dose dexamethasone in infancy.

  2019cites this paper
• Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT

  2019cites this paper
• Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.

  2019cites this paper
• Stem Cell Composition of Umbilical Cord Blood Following Milking Compared with Delayed Clamping of the Cord Appears Better Suited for Promoting Hematopoiesis.

  2019cites this paper
• Antenatal betamethasone enhanced the detrimental effects of postnatal dexamethasone on hyperoxic lung and brain injuries in newborn rats

  2019cites this paper
• ACUTE AND CHRONIC SIDE EFFECTS OF CORTICOSTEROIDS USED FOR TREATMENT OF NEONATAL CONDITIONS

  2019cites this paper
• Cerebral Palsy: Diagnosis, Epidemiology, Genetics, and Clinical Update.

  2019cites this paper
• Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.

  2019cites this paper
• Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.

  2019cites this paper
• Bronchopulmonary Dysplasia: 50 Years after the Original Description

  2019cites this paper
• Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.

  2019cites this paper
• Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies.

  2019cites this paper
• Health Care-Associated Infections

  2018cites this paper
• Bronchopulmonary dysplasia: Pathogenesis and treatment.

  2018influential citation
• Postnatal steroids: still a dilemma for neonatologists and parents?

  2018cites this paper
• Factors affecting neurodevelopmental outcome at 2 years in very preterm infants below 1250 grams: a prospective study

  2018cites this paper
• Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm

  2018cites this paper
• Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis

  2018cites this paper
• Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis

  2018cites this paper
• Early low-dose hydrocortisone: is the neurodevelopment affected?

  2018cites this paper
• Does inhaled budesonide for bronchopulmonary dysplasia affect the neurodevelopmental outcomes?

  2018cites this paper
• Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes

  2018cites this paper
• Cognitive Development and Quality of Life Associated With BPD in 10-Year-Olds Born Preterm

  2018cites this paper
• Interventions to Improve Rates of Successful Extubation in Preterm Infants: A Systematic Review and Meta-analysis

  2017cites this paper
• Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.

  2017cites this paper
• Étude épidémiologique de la grande prématurité au CHU de Rouen : comparaison des années 2000, 2005, 2010 et 2015

  2017cites this paper
• Can We Prevent Bronchopulmonary Dysplasia?

  2017cites this paper
• Overview of systematic reviews of therapeutic ranges: methodologies and recommendations for practice

  2017cites this paper
• Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone

  2017influential citation
• Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?

  2017cites this paper
• Pulmonary Disease (Chronic Lung Disease) in Infants; Overview of Proper Management

  2017cites this paper
• Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

  2017cites this paper